We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
GM Biopharmaceuticals, Inc. announced that the company has entered into an amended and restated agreement with Merck to extend their ongoing collaboration through March 2024 but with a narrower scope.